News Daily News FFR Values Linked to Quality-of-Life Improvement After PCI in Stable CAD Patients Todd Neale September 21, 2018
News Daily News ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights Michael O'Riordan July 10, 2018
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for May 2018 Caitlin E. Cox June 01, 2018
News Conference News EuroPCR 2018 Modest Benefit of PCI Over Medical Therapy in Patients With ‘Grey Zone’ FFR Lesions Michael O'Riordan May 23, 2018
News Conference News EuroPCR 2018 FFR in PCI for Stable CAD: Lasting Benefit Shown by FAME 2, SCAAR Data Caitlin E. Cox May 22, 2018
News Conference News EuroPCR 2018 New ORBITA Insights: Invasive Physiology Tests Track Closely With Ischemia, but Not Symptom Improvement Shelley Wood May 22, 2018
Presentation EuroPCR 2018 ORBITA: A Physiology-stratified Analysis of the Impact of FFR and iFR on Efficacy of Coronary Angioplasty in Stable Coronary Artery Disease Presenter: Rasha Al-Lamee May 22, 2018
News Conference News EuroPCR 2018 FFR-Guided PCI Reduces Risk of Death/MI Compared With Medical Therapy: Pooled Analysis Michael O'Riordan May 22, 2018
Presentation Intravascular Coronary Imaging and Physiology 2018 ORBITA Trial Presenter: Paul S. Teirstein May 05, 2018
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for April 2018 Caitlin E. Cox April 30, 2018
News Conference News ACC 2018 ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last Shelley Wood March 05, 2018